Read Scott like a free app: tap then Add to Home Screen. Read Scott like a free app: tap then Add app to Home screen. Add Read Scott Alexander to your home screen to read it like an app.
Want to dive into Scott Alexander's work and his thousands of blog posts? This fan website lets you sort and do semantic search through the whole codex. Enjoy!
| Date | ||
| Length | ||
| Likes | ||
| Comments |
Scott Alexander examines Zulresso and Zuranolone, two neurosteroid drugs for postpartum depression, discussing their efficacy, challenges, and potential future applications.
Scott provides updates on efforts to get FDA approval for fluvoxamine as a COVID-19 treatment and reports on the early approval of Paxlovid.
Scott Alexander critiques the FDA's slow approval process for Paxlovid, a promising COVID-19 treatment, despite its proven effectiveness.
Scott Alexander examines the treatment for progeria and its potential implications for understanding and treating normal aging processes.
Scott Alexander critiques the FDA approval of esketamine for depression, discussing issues with drug development, efficacy, cost, and administration requirements.
Read Scott like a free app: tap then Add to Home Screen. Read Scott like a free app: tap then Add app to Home screen. Add Read Scott Alexander to your home screen to read it like an app.